HomeDepartmentsCardiovascular EngineeringTeam


Dr. rer. nat. Christiane Rosefort

Group Leader Valve Replacement & Interventions

 

Projects:

INTER-Heart

 

 

HIA Room 1.01
+49 241 80 88616
rosefort(at)hia.rwth-aachen.de


Education

Studies

  • Biology (Diploma) University of Marburg and TU Kaiserslautern
    Main focus: Human biology, Genetics, Phytology
    Subsidiary subject
    : Food chemistry / Environmental toxicology

Further Education

  • Certified quality manager (ISO 9001; ZDH-Zert.)
  • Certified project management associate (GPM, IPMA Level D)

Work

  • (since 2010) Research assistant
    Helmholtz-Institute, RWTH Aachen
    Institute of Applied Medical Engineering (AME)
    Dept. of Cardiovascular Engineering (CVE)

  • (2010) Research assistant (PostDoc)
    University Hospital, RWTH University; Aachen
    Institute of pharmacology and toxicology
    Dept. of molecular pharmacology
  • (2006-2009) Research assistant (Dissertation)
    University Hospital, RWTH University; Aachen
    Institute of pharmacology and toxicology
    Dept. of molecular pharmacology


Publications

Dissertation

  • Rosefort C: Elektrophysiologische Charakterisierung eines neuen heteromeren P2X-Rezeptors, einer P2X-Chimäre und neuer P2X-Rezeptor-Antagonisten. Aachen, 2010. - 147, XIII S. : graph. Darst. Aachen, Techn. Hochsch., Diss., 2010

Articles

Conference

  • Rosefort C, Kütting M, Pott D, Schmitz S, Sonntag S, Sedaghat A, Vodiškar J, Steinseifer U: Nursing innovations in cardiovascular therapies by quality and project management structures at a university level. International Journal of Artificial Organs 2014, 41st Annual ESAO Congress (Rom, 18.09. - 21.09.2014)
  • Rosefort C, Kütting M, Fiehe S, Steinseifer U: Development of customizable heart valve protheses for acquired and congenital diseases of the RVOT. International Journal of Artificial Organs 2014, 41st Annual ESAO Congress (Rom, 18.09. - 21.09.2014)

Posters

  • Rosefort C, Fiehe S, Kütting M, Steinseifer U: Nursing innovations in cardiovascular therapies by integration of quality and project management structures at a university level. ICI Meeting 2013 (Tel Aviv, 01.12. - 03.12.2013)
  • Baqi Y, Rosefort C, Hausmann R, Müller CE: Development of the first potent P2X2 receptor antagonists. Purinergic Signalling, 6 (1; Suppl.) (2010)
    Purines 2010 Meeting (Tarragona-Barcelona, 30.05. - 02.06.2010)
  • Hausmann R, Wolf C, Rosefort C, Kassack M, Schmalzing G: The suramin derivatives NF770 and NF778 are nanomolar potent antagonists of recombinant rat P2X2 receptors. Purinergic Signalling, 4 (1; Suppl.) (2008)
    Purines 2008 Meeting (Copenhagen, 29.06. - 02.07.2008)
  • Rosefort C, Duckwitz W, Hausmann R und Schmalzing G: Identification of P2X1 ectodomain residues important for channel assembly and function
    Second Joint Italian-German Purine Club Meeting (Leipzig, 12.-15.09.2007)
  • El-Wahsch D, Fallah G, Eisele T, Rosefort C, Hausmann R und Schmalzing G: Role of disulfide bond formation on the assembly and cell surface expression of P2X1-receptors
    Second Joint Italian-German Purine Club Meeting (Leipzig, 12.-15.09.2007)
  • Rosefort C, Fauth E und Zankl H: A fast assay to distinguish aneugens from clastogens by the cytokinesis-block micronucleus assay. Naunyn-Schmiedeberg´s Archives of Pharmacology, 367 (Suppl. 1), A637 (2003)
    44. Frühjahrstagung der DPTG